Rchr
J-GLOBAL ID:201201092609639321   Update date: Sep. 17, 2019

YAO Masahiro

ヤオ マサヒロ | YAO Masahiro
Affiliation and department:
Job title: Professor
Homepage URL  (1): http://www-user.yokohama-cu.ac.jp/~urology/wp/
Research field  (3): Human genetics ,  Pathological medical chemistry ,  Urology
Research theme for competitive and other funds  (7):
  • 2009 - 2011 Identification of gene signatures associated with renal tumor characteristics and its clinical applications
  • 2006 - 2007 Construction of gene-expression predictor model for patient outcome with renal cell carcinoma
  • 2004 - 2006 Prediction Model for Renal Carcinoma Recurrence based on the Gene Expressions.
  • 2001 - 2002 Analysis of the VHL Tumor Suppressor Gene in Kidney Cancer
  • 1998 - 1999 Functional Analysis of the von Hippel-Lindau Disease Tumor Suppressor Gene
Show all
Papers (183):
  • Baba M, Furuya M, Motoshima T, Lang M, Funasaki S, Ma W, Sun HW, Hasumi H, Huang Y, Kato I, Kadomatsu T, Satou Y, Morris N, Karim BO, Ileva L, Kalen JD, Wilan Krisna LA, Hasumi Y, Sugiyama A, Kurahashi R, Nishimoto K, Oyama M, Nagashima Y, Kuroda N, Araki K, Eto M, Yao M, Kamba T, Suda T, Oike Y, Schmidt LS, Linehan WM. TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease. Molecular cancer research : MCR. 2019. 17. 8. 1613-1626
  • Kanehira K, Yano Y, Hasumi H, Fukuhara H, Inoue K, Hanazaki K, Yao M. Fluorescence Enhancement Effect of TiO2 Nanoparticles and Application for Photodynamic Diagnosis. International journal of molecular sciences. 2019. 20. 15
  • Tomita Y, Fukasawa S, Shinohara N, Kitamura H, Oya M, Eto M, Tanabe K, Saito M, Kimura G, Yonese J, Yao M, Uemura H. Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study. Japanese journal of clinical oncology. 2019. 49. 6. 506-514
  • Kawahara T, Takeshima T, Miyoshi Y, Nakaigawa N, Yao M, Tanabe M, Uemura H. Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib. Case reports in oncology. 2019. 12. 2. 543-547
  • Kawahara T, Mochizuki T, Sugimura R, Izumi K, Kuroda S, Miyoshi Y, Nakaigawa N, Yao M, Tanabe M, Uemura H. Successful Resection of Cisplatin-Resistant Renal Pelvic Cancer after the Administration of Pembrolizumab as Second-Line Therapy. Case reports in oncology. 2019. 12. 2. 548-553
more...
MISC (44):
Association Membership(s) (6):
JAPANESE SOCIETY OF GERIATRIC UROLOGY ,  LOW TEMPERATURE MEDICINE ,  THE JAPAN SOCIETY OF HUMAN GENETICS ,  THE JAPANESE CANCER ASSOCIATION ,  JAPAN SOCIETY OF CLINICAL ONCOLOGY ,  THE JAPANESE UROLOGICAL ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page